Stocks · Healthcare · Medical - Care Facilities
Surgery Partners, Inc. SGRY
$13.32 +0.68% Close, Oct 2, 2026 · NASDAQ · Market cap $1.74B
Inexpensive vs sector
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Net debt is 4.0× EBITDA, a high level of leverage.
- Over the past year the stock returned -37.1%, behind the S&P 500 by 52.2 percentage points.
- The stock is 42% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 37%
- FCF growth (TTM, YoY)Bottom 48%
- Revenue growth, 3-year CAGRBottom 47%
- Revenue growth accelerationBottom 38%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 25%
- Gross marginBottom 15%
- Operating marginTop 23%
- Accruals (lower is better)Bottom 38%
- Net debt / EBITDA (lower is better)Bottom 20%
- Interest coverTop 42%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 44%
- Free-cash-flow yieldTop 6%
- EBITDA / enterprise valueTop 4%
- Sales / enterprise valueTop 20%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 14%
- 6-month returnTop 48%
- 1-year return vs S&P 500Bottom 17%
- Distance from 52-week highBottom 37%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 30%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 29%
- Upside to consensus price targetBottom 37%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 41%
- Maximum drawdown, 3 yearsTop 46%
- Beta vs S&P 500 (lower is better)Bottom 43%
- Net debt / EBITDA (lower is better)Bottom 20%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 5.4% | 4.0% | ↓ |
| Gross margin | 23.7% | 21.4% | ↓ |
| Operating margin | 11.2% | 11.9% | ↑ |
| FCF margin | 5.4% | 5.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 4.0% | 5.4% | ↓ | Bottom 37% |
| Gross margin | 21.4% | 23.7% | ↓ | Bottom 15% |
| Operating margin | 11.9% | 11.2% | ↑ | Top 23% |
| Net margin | -2.6% | -5.6% | ↑ | — |
| Free-cash-flow margin | 5.6% | 5.4% | ↑ | — |
| Return on invested capital | 4.4% | — | Top 25% | |
| Revenue growth, 3-year CAGR | 9.2% | — | Bottom 47% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +5.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 4.01×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 0.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.00%
- Shareholder yield
- 0.00%
- Share count change, 1 year
- +1.5%
- Share count change, 3-year CAGR
- +0.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +14.9%
- Average 2-day reaction, last 8
- -2.7%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $18.00
- Target vs current price
- +35.1%
- Analysts with a rating
- 22
- Share rating Buy or Strong Buy
- 64%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | +72.6% | +2.7% | -3.2% | -8.2% | — |
| May 5, 2026 | +80.0% | +0.4% | -3.0% | -3.0% | +12.0% |
| Mar 2, 2026 | -61.3% | +2.5% | -13.8% | -25.9% | -13.2% |
| Nov 10, 2025 | -31.6% | -25.4% | -28.9% | -22.2% | -37.5% |
| Aug 5, 2025 | +6.3% | -0.4% | +2.3% | +1.6% | +3.2% |
| May 12, 2025 | -50.0% | +5.0% | +8.0% | +5.4% | +1.1% |
| Mar 3, 2025 | +15.8% | -0.3% | -0.1% | -0.5% | -4.3% |
| Nov 12, 2024 | -24.0% | -5.9% | -30.5% | -31.4% | -18.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | $0.10 | $0.06 | +72.6% | $848.9M |
| May 5, 2026 | -$0.03 | -$0.15 | +80.0% | $810.9M |
| Mar 2, 2026 | $0.12 | $0.31 | -61.3% | $885.0M |
| Nov 10, 2025 | $0.13 | $0.19 | -31.6% | $821.5M |
| Aug 5, 2025 | $0.17 | $0.16 | +6.3% | $826.2M |
| May 12, 2025 | $0.04 | $0.08 | -50.0% | $776.0M |
| Mar 3, 2025 | $0.44 | $0.38 | +15.8% | $864.4M |
| Nov 12, 2024 | $0.19 | $0.25 | -24.0% | $770.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 32.7× | — | — | — |
| EV / EBITDA | 5.8× | — | — | Top 4% |
| EV / Sales | 1.65× | — | — | Top 20% |
| Free-cash-flow yield | 10.77% | — | — | Top 6% |
| Earnings yield | -5.18% | — | — | Top 44% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -5.6%
- 200-day average slope (20 days)
- -1.6%
- Distance from 50-day average
- -8.3%
- Distance from 200-day average
- -8.3%
- RSI (14)
- 42.8
- Relative volume
- 0.52×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 60.4%
- Volatility vs own 5-year history
- 69th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.24
- Correlation with S&P 500
- 0.36
- Current drawdown from 1-year high
- -41.9%
- Maximum drawdown, 3 years
- -67.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 25, 2021 | Mar 27, 2026 | -82.9% | 1193 days | Not yet recovered |
| Feb 1, 2021 | Feb 9, 2021 | -14.3% | 6 days | 13 days (Mar 1, 2021) |
| Nov 10, 2020 | Nov 12, 2020 | -12.5% | 2 days | 14 days (Dec 3, 2020) |
| Oct 5, 2020 | Oct 27, 2020 | -10.1% | 16 days | 5 days (Nov 3, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.74B
- EPS, diluted (TTM)
- -$0.69
- Revenue (TTM)
- $3.37B
- 52-week range
- $11.41 – $23.44
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.23B | $2.54B | $2.74B | $3.11B | $3.31B |
| Gross profit | $491.4M | $574.9M | $647.5M | $745.6M | $765.0M |
| Operating income | $302.2M | $345.2M | $328.0M | $348.8M | $389.5M |
| Net income | -$70.9M | -$54.6M | -$11.9M | -$168.1M | -$77.9M |
| EPS (diluted) | -$1.12 | -$0.59 | -$0.09 | -$1.33 | -$0.61 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $770.4M | $864.4M | $776.0M | $826.2M | $821.5M | $885.0M | $810.9M | $848.9M |
| Net income | -$31.7M | -$108.5M | -$37.7M | -$2.5M | -$22.7M | -$15.0M | -$35.9M | -$15.0M |
| EPS (diluted) | -$0.25 | -$0.86 | -$0.30 | -$0.02 | -$0.18 | -$0.11 | -$0.28 | -$0.12 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $87.1M | $158.8M | $293.8M | $300.1M | $274.3M |
| Capital expenditure | -$57.6M | -$80.6M | -$88.8M | -$90.4M | -$78.7M |
| Free cash flow | $29.5M | $78.2M | $205.0M | $209.7M | $195.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $581.8M | $882.9M | $0 | $0 | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $216.7M
- Total assets
- $8.05B
- Total liabilities
- $4.95B
- Total debt
- $4.02B
- Net debt
- $3.80B
- Shareholders’ equity
- $1.67B
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 13,288,944
- Days to cover
- 6.37
- Change vs previous report
- +2.6%
FINRA short interest, settlement date Sep 15, 2026.